Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


Pluristem Initiates Final Validation of New Manufacturing Facility 

 

December 27, 2012 - (Pluristem) - "Pluristem Therapeutics, Inc., a leading developer of placenta-based cell therapies, announced today it has initiated the final validation steps for it new "state-of-the-art" manufacturing facility prior to taking possession of the facility." Read Full Article

 

Posted on 9-Jan-13 by Toto, Brent
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: